Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Aspirin for the Prevention of Preeclampsia and Pregnancy Outcomes in Nulliparous Women After Assisted Reproductive Technology. APPART

NCT05625724 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.

NCT NCT05625724
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05625724 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Aspirin for the Prevention of Preeclampsia and Pregnancy Outcomes in Nulliparous Women After Assisted Reproductive Technology. APPART
Lead sponsor
University Hospital, Toulouse
Phase
Phase 3
Overall status
Recruiting
Start date
August 2, 2023
Completion date
May 31, 2029
Enrollment
1,164 (estimated)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

art, pre-eclampsia